Maze Therapeutics

MAZE · NASDAQ

$32.45+$2.75 (+9.26%)TodayMarket closed ·
Prev close $29.70

Who owns MAZE

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 58.6% of MAZE’s shares.

  • Third Rock Ventures, LLC9.8%
  • Frazier Life Sciences Management, L.P.9.1%
  • ARCH Venture Partners7.4%
  • Deep Track Capital LP6.7%
  • Next 6 largest institutions25.5%
  • All other shareholders41.4%
Top institutional holders of MAZE
HolderShares% of shares
Third Rock Ventures, LLC5.42M9.80%
Frazier Life Sciences Management, L.P.5.03M9.09%
ARCH Venture Partners4.12M7.44%
Deep Track Capital LP3.73M6.74%
Janus Henderson Investors3.41M6.16%
BlackRock Institutional Trust Company, N.A.2.71M4.90%
T. Rowe Price Investment Management, Inc.2.60M4.70%
Logos Global Management LP1.94M3.50%
Vanguard Capital Management, LLC1.78M3.21%
Andreessen Horowitz1.70M3.08%

Largest mutual fund holders

Top mutual fund holders of MAZE
HolderShares% of shares
Vanguard Total Stock Market Index Fund1.41M2.55%
iShares Russell 2000 ETF916.28K1.66%
Fidelity Select Biotechnology Portfolio782.46K1.41%
Janus Henderson Horizon Biotechnology692.97K1.25%
JPMorgan Small Cap Growth Fund551.52K1.00%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $10.71M (53 trades) of MAZE on the open market, with no buys.

Latest MAZE insider transactions
InsiderTypeSharesValue
Bernstein HaroldOption exercise16.14K—
Bernstein HaroldSale16.14K$434.74K
Bernstein HaroldOption exercise16.14K$168.19K
Coloma Jason VSale31.91K$862.19K
Coloma Jason VSale2.59K$70.07K
Dandekar AtulOption exercise7.50K—
Dandekar AtulSale7.50K$202.92K
Dandekar AtulOption exercise7.50K$78.15K
Bernstein HaroldSale9.71K$254.50K
Bernstein HaroldSale59$1.52K

Short interest

Settled Sep 30, 2026

Shares short
6.57M
Days to cover
6.07
% of shares outstanding
11.86%
Average daily volume
1.08M
Change since last report
+15.6%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.